⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Official Title: An Open-Label Extension Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

Study ID: NCT04650854

Interventions

Rozanolixizumab

Study Description

Brief Summary: The purpose of this study is to assess the safety, tolerability and efficacy of additional 6-week treatment cycles with rozanolixizumab in study participants with generalized myasthenia gravis (gMG).

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Mg0007 50092, Orange, California, United States

Mg0007 50099, San Francisco, California, United States

Mg0007 50122, Miami, Florida, United States

Mg0007 50120, Miami, Florida, United States

Mg0007 50073, Tampa, Florida, United States

Mg0007 50075, Augusta, Georgia, United States

Mg0007 50323, Honolulu, Hawaii, United States

Mg0007 50114, Indianapolis, Indiana, United States

Mg0007 50121, Lexington, Kentucky, United States

Mg0007 50077, New York, New York, United States

Mg0007 50090, Winston-Salem, North Carolina, United States

Mg0007 50096, Philadelphia, Pennsylvania, United States

Mg0007 50113, Houston, Texas, United States

Mg0007 50071, Edmonton, , Canada

Mg0007 50066, Montreal, , Canada

Mg0007 50124, Montreal, , Canada

Mg0007 50070, Quebec, , Canada

Mg0007 50069, Toronto, , Canada

Mg0007 40125, Ostrava - Poruba, , Czechia

Mg0007 40124, Praha 2, , Czechia

Mg0007 40128, Aalborg, , Denmark

Mg0007 40127, Aarhus, , Denmark

Mg0007 40126, Copenhagen, , Denmark

Mg0007 40129, Bordeaux, , France

Mg0007 40360, Limoges, , France

Mg0007 40132, Nice Cedex 1, , France

Mg0007 40133, Paris, , France

Mg0007 40131, Strasbourg, , France

Mg0007 20160, Tbilisi, , Georgia

Mg0007 20161, Tbilisi, , Georgia

Mg0007 20163, Tbilisi, , Georgia

Mg0007 20164, Tbilisi, , Georgia

Mg0007 20165, Tbilisi, , Georgia

Mg0007 40134, Essen, , Germany

Mg0007 40140, Göttingen, , Germany

Mg0007 40139, Jena, , Germany

Mg0007 40078, Leipzig, , Germany

Mg0007 40177, Münster, , Germany

Mg0007 40283, Bologna, , Italy

Mg0007 40144, Milano, , Italy

Mg0007 40307, Napoli, , Italy

Mg0007 40146, Pavia, , Italy

Mg0007 40148, Roma, , Italy

Mg0007 40150, Roma, , Italy

Mg0007 20035, Bunkyo-ku, , Japan

Mg0007 20068, Chiba-shi, , Japan

Mg0007 20078, Hanamaki-shi, , Japan

Mg0007 20079, Hiroshima, , Japan

Mg0007 20075, Kobe, , Japan

Mg0007 20071, Nagasaki-shi, , Japan

Mg0007 20077, Sendai, , Japan

Mg0007 20070, Shinjuku-ku, , Japan

Mg0007 20076, Shinjuku-ku, , Japan

Mg0007 20032, Suita, , Japan

Mg0007 40155, Gdansk, , Poland

Mg0007 40154, Lodz, , Poland

Mg0007 40151, Lublin, , Poland

Mg0007 40153, Poznan, , Poland

Mg0007 20169, Novosibirsk, , Russian Federation

Mg0007 20001, Saint-petersburg, , Russian Federation

Mg0007 20028, Saint-petersburg, , Russian Federation

Mg0007 20055, Saint-petersburg, , Russian Federation

Mg0007 40467, NIS, , Serbia

Mg0007 40160, Barcelona, , Spain

Mg0007 40157, Hospitalet de Llobregat, , Spain

Mg0007 40350, Murcia, , Spain

Mg0007 40308, San Sebastián de Los Reyes, , Spain

Mg0007 20081, Taipei City, , Taiwan

Mg0007 20086, Taipei City, , Taiwan

Contact Details

Name: UCB Cares

Affiliation: 001 844 599 22733 (UCB)

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: